Episode 483: AARON SIRI AT THE KENNEDY CENTER: A Turning Point for Informed Consent

The Highwire with Del Bigtree by The Highwire with Del Bigtree

Jul 2, 2026117:48News & Politics

As America marks 250 years since the signing of the Declaration of Independence, “The HighWire” celebrates freedom the only way it knows how: by defending the right to bodily sovereignty. Del talks to ICAN lead attorney...

Related Episodes

Continue listening to more episodes from The Highwire with Del Bigtree.

Episode 492: FLORIDA LEADS THE PACK, CELEBS DEMAND ANSWERS & BEHIND THE 'CLEAN FOOD' INDUSTRY

Sep 3, 2026 - 103:31

Florida makes a dramatic move against vaccine mandates as Dr. Joseph Ladapo charts a new course for famil...

Episode 491: MEASLES BLAME GAME, FAUCI LAWYERS UP & THE CLANCY PHARMA CONNECTION

Aug 27, 2026 - 110:29

A battle erupts between RFK Jr. and Pennsylvania Governor Josh Shapiro over two “measles-associated” deat...

Episode 490: MASS SURVEILLANCE 2.0, AVOCADO OIL FRAUD & HOMEOPATHY’S COMEBACK

Aug 20, 2026 - 76:11

The surveillance state may be entering a dangerous new phase. You’ve heard the warnings about Flock camer...

Episode 489: mRNA’S NEW TARGET, FARM BILL FIGHT & SEARCHING FOR “THEY” IN FRANCE

Aug 13, 2026 - 112:08

A new mRNA vaccine is entering the spotlight, and Del is asking whether the lessons we learned during COV...

Episode 488: THE FAUCI FIRESTORM

Aug 6, 2026 - 92:42

The fallout from Anthony Fauci’s Fifth Amendment testimony is exploding as the Senate Homeland Security C...

Episode 487: SCIENCE PLEADS THE 5TH

Jul 30, 2026 - 102:37

Anthony “I Plead the Fifth” Fauci finally faced senators after the release of more than 1,000 pages of hi...

Episode 486: SUPER SURVEILLANCE, TOXIC STRAWBERRIES & AUTISM BEYOND “THE TREND”

Jul 23, 2026 - 84:44

Del returns from CPAC UK with a surprising look at how many prominent European leaders are openly embraci...

Episode 485: THE PEPTIDE DIVIDE: HYPE, HOPE & HARD TRUTHS

Jul 21, 2026 - 98:04

Del returns from FreedomFest with a major win for “An Inconvenient Study,” which took home two awards at...